INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2177120, encodeId=2cde21e7120e3, content=为什么投稿进不去啊，一直在转, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a719117663, createdName=ms8000001464351306, createdTime=Mon Dec 25 17:10:40 CST 2023, time=2023-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167586, encodeId=87af216e58630, content=请问投稿后一直都是pending review状态吗，怎么知道有没有到编辑手里或者送外审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:26:55 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167584, encodeId=d6a7216e584c5, content=请问这个杂志投稿后状态就一直是Pending review吗，怎么知道有没有到编辑手里，或者送审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:22:01 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2173930, encodeId=5abe21e3930ac, content=请问对中药复方友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Dec 09 21:54:05 CST 2023, time=2023-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173133, encodeId=ca4121e313333, content=求问：投稿后page count显示1是怎么回事啊？是上传的问题吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue Dec 05 23:37:30 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省)]

2023-12-25 ms8000001464351306 来自湖北省

为什么投稿进不去啊，一直在转

27 0

[GetPortalCommentsPageByObjectIdResponse(id=2177120, encodeId=2cde21e7120e3, content=为什么投稿进不去啊，一直在转, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a719117663, createdName=ms8000001464351306, createdTime=Mon Dec 25 17:10:40 CST 2023, time=2023-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167586, encodeId=87af216e58630, content=请问投稿后一直都是pending review状态吗，怎么知道有没有到编辑手里或者送外审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:26:55 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167584, encodeId=d6a7216e584c5, content=请问这个杂志投稿后状态就一直是Pending review吗，怎么知道有没有到编辑手里，或者送审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:22:01 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2173930, encodeId=5abe21e3930ac, content=请问对中药复方友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Dec 09 21:54:05 CST 2023, time=2023-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173133, encodeId=ca4121e313333, content=求问：投稿后page count显示1是怎么回事啊？是上传的问题吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue Dec 05 23:37:30 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省)]

2023-04-02 sci快到碗里来来自四川省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：神经科学;医学
经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，

63 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177120, encodeId=2cde21e7120e3, content=为什么投稿进不去啊，一直在转, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a719117663, createdName=ms8000001464351306, createdTime=Mon Dec 25 17:10:40 CST 2023, time=2023-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167586, encodeId=87af216e58630, content=请问投稿后一直都是pending review状态吗，怎么知道有没有到编辑手里或者送外审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:26:55 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167584, encodeId=d6a7216e584c5, content=请问这个杂志投稿后状态就一直是Pending review吗，怎么知道有没有到编辑手里，或者送审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:22:01 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2173930, encodeId=5abe21e3930ac, content=请问对中药复方友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Dec 09 21:54:05 CST 2023, time=2023-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173133, encodeId=ca4121e313333, content=求问：投稿后page count显示1是怎么回事啊？是上传的问题吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue Dec 05 23:37:30 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省)]

2023-11-09 青青子衿来自山东省

请问投稿后一直都是pending review状态吗，怎么知道有没有到编辑手里或者送外审了呀？

27 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177120, encodeId=2cde21e7120e3, content=为什么投稿进不去啊，一直在转, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a719117663, createdName=ms8000001464351306, createdTime=Mon Dec 25 17:10:40 CST 2023, time=2023-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167586, encodeId=87af216e58630, content=请问投稿后一直都是pending review状态吗，怎么知道有没有到编辑手里或者送外审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:26:55 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167584, encodeId=d6a7216e584c5, content=请问这个杂志投稿后状态就一直是Pending review吗，怎么知道有没有到编辑手里，或者送审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:22:01 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2173930, encodeId=5abe21e3930ac, content=请问对中药复方友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Dec 09 21:54:05 CST 2023, time=2023-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173133, encodeId=ca4121e313333, content=求问：投稿后page count显示1是怎么回事啊？是上传的问题吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue Dec 05 23:37:30 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省)]

2022-11-04 ms8000000438373883

收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome.

59 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177120, encodeId=2cde21e7120e3, content=为什么投稿进不去啊，一直在转, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a719117663, createdName=ms8000001464351306, createdTime=Mon Dec 25 17:10:40 CST 2023, time=2023-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167586, encodeId=87af216e58630, content=请问投稿后一直都是pending review状态吗，怎么知道有没有到编辑手里或者送外审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:26:55 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167584, encodeId=d6a7216e584c5, content=请问这个杂志投稿后状态就一直是Pending review吗，怎么知道有没有到编辑手里，或者送审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:22:01 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2173930, encodeId=5abe21e3930ac, content=请问对中药复方友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Dec 09 21:54:05 CST 2023, time=2023-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173133, encodeId=ca4121e313333, content=求问：投稿后page count显示1是怎么回事啊？是上传的问题吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue Dec 05 23:37:30 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省)]

2023-11-09 青青子衿来自山东省

请问这个杂志投稿后状态就一直是Pending review吗，怎么知道有没有到编辑手里，或者送审了呢？

31 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177120, encodeId=2cde21e7120e3, content=为什么投稿进不去啊，一直在转, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a719117663, createdName=ms8000001464351306, createdTime=Mon Dec 25 17:10:40 CST 2023, time=2023-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167586, encodeId=87af216e58630, content=请问投稿后一直都是pending review状态吗，怎么知道有没有到编辑手里或者送外审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:26:55 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167584, encodeId=d6a7216e584c5, content=请问这个杂志投稿后状态就一直是Pending review吗，怎么知道有没有到编辑手里，或者送审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:22:01 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2173930, encodeId=5abe21e3930ac, content=请问对中药复方友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Dec 09 21:54:05 CST 2023, time=2023-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173133, encodeId=ca4121e313333, content=求问：投稿后page count显示1是怎么回事啊？是上传的问题吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue Dec 05 23:37:30 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省)]

2023-12-09 ms4000001105476217 来自北京

请问对中药复方友好吗

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2177120, encodeId=2cde21e7120e3, content=为什么投稿进不去啊，一直在转, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a719117663, createdName=ms8000001464351306, createdTime=Mon Dec 25 17:10:40 CST 2023, time=2023-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167586, encodeId=87af216e58630, content=请问投稿后一直都是pending review状态吗，怎么知道有没有到编辑手里或者送外审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:26:55 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167584, encodeId=d6a7216e584c5, content=请问这个杂志投稿后状态就一直是Pending review吗，怎么知道有没有到编辑手里，或者送审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:22:01 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2173930, encodeId=5abe21e3930ac, content=请问对中药复方友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Dec 09 21:54:05 CST 2023, time=2023-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173133, encodeId=ca4121e313333, content=求问：投稿后page count显示1是怎么回事啊？是上传的问题吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue Dec 05 23:37:30 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省)]

2023-12-05 ms4000001668897773 来自北京

求问：投稿后page count显示1是怎么回事啊？是上传的问题吗？

28 0

[GetPortalCommentsPageByObjectIdResponse(id=2177120, encodeId=2cde21e7120e3, content=为什么投稿进不去啊，一直在转, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a719117663, createdName=ms8000001464351306, createdTime=Mon Dec 25 17:10:40 CST 2023, time=2023-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167586, encodeId=87af216e58630, content=请问投稿后一直都是pending review状态吗，怎么知道有没有到编辑手里或者送外审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:26:55 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167584, encodeId=d6a7216e584c5, content=请问这个杂志投稿后状态就一直是Pending review吗，怎么知道有没有到编辑手里，或者送审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:22:01 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2173930, encodeId=5abe21e3930ac, content=请问对中药复方友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Dec 09 21:54:05 CST 2023, time=2023-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173133, encodeId=ca4121e313333, content=求问：投稿后page count显示1是怎么回事啊？是上传的问题吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue Dec 05 23:37:30 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省)]

2023-09-12 ms4000000352004046 来自江苏省

偏重的研究方向：生物信息学;分子医学
经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊

37 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177120, encodeId=2cde21e7120e3, content=为什么投稿进不去啊，一直在转, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a719117663, createdName=ms8000001464351306, createdTime=Mon Dec 25 17:10:40 CST 2023, time=2023-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167586, encodeId=87af216e58630, content=请问投稿后一直都是pending review状态吗，怎么知道有没有到编辑手里或者送外审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:26:55 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167584, encodeId=d6a7216e584c5, content=请问这个杂志投稿后状态就一直是Pending review吗，怎么知道有没有到编辑手里，或者送审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:22:01 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2173930, encodeId=5abe21e3930ac, content=请问对中药复方友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Dec 09 21:54:05 CST 2023, time=2023-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173133, encodeId=ca4121e313333, content=求问：投稿后page count显示1是怎么回事啊？是上传的问题吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue Dec 05 23:37:30 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省)]

2023-09-28 ms5000000116399737 来自湖北省

偏重的研究方向：生物信息学;肿瘤;癌症
经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受

49 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177120, encodeId=2cde21e7120e3, content=为什么投稿进不去啊，一直在转, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a719117663, createdName=ms8000001464351306, createdTime=Mon Dec 25 17:10:40 CST 2023, time=2023-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123324, encodeId=09ce212332414, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：神经科学;医学 经验分享：投稿第二天送审，10天返修，一周内修了2次，后录用。从投稿到接受总共加起来半个月吧，速度是没的说！但是老实说，我的研究配不上6分的期刊，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=sci快到碗里来, createdTime=Sun Apr 02 22:24:51 CST 2023, time=2023-04-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167586, encodeId=87af216e58630, content=请问投稿后一直都是pending review状态吗，怎么知道有没有到编辑手里或者送外审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:26:55 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167584, encodeId=d6a7216e584c5, content=请问这个杂志投稿后状态就一直是Pending review吗，怎么知道有没有到编辑手里，或者送审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/3UFkw7xXAbD1M1zODQH1tiarMwsIRicwmgiaOtlV0ia1Oo00jkGgXSpAqKWuUx1Hz3vsqRv7s0NjKjt4CSxnT66MmA/132, createdBy=57b95280538, createdName=青青子衿, createdTime=Thu Nov 09 15:22:01 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2173930, encodeId=5abe21e3930ac, content=请问对中药复方友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Dec 09 21:54:05 CST 2023, time=2023-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173133, encodeId=ca4121e313333, content=求问：投稿后page count显示1是怎么回事啊？是上传的问题吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue Dec 05 23:37:30 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157282, encodeId=3631215e28241, content=偏重的研究方向：生物信息学;分子医学 经验分享：9.8投了篇纯生信，，，还是p e n d in g r ev i e w，要拒也麻烦快一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29968843690, createdName=ms4000000352004046, createdTime=Tue Sep 12 10:48:42 CST 2023, time=2023-09-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省)]

2023-06-16 ms7000001030262158 来自陕西省

pending review14天了。。也不知道是好消息还是坏消息。。

0 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务